JDRF-funded studies show regular CGM use increases diabetes control for all age groups

The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors -- six days per week or more -- rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices -- including experiencing fewer low blood sugar emergencies.